Drug and therapeutics committees in Nigeria: evaluation of scope and functionality
- 30 November 2018
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Clinical Pharmacology
- Vol. 11 (12) , 1255-1262
Abstract
Introduction: Inappropriate use of medicines remains a problem, with consequences including increasing adverse drug reactions (ADRs) and prolonged hospitalizations. The Essential Medicines List and Drug and Therapeutics Committees (DTCs) are accepted initiatives to promote the rational use of medicines. However, little is known about DTC activities in Nigeria, the most populous African country. Areas covered: A cross-sectional questionnaire-based study was conducted among senior pharmacists, consultant physicians, and clinical pharmacologists in 12 leading tertiary health-care facilities across Nigeria. Expert commentary: Six (50%, 6/12) health-care facilities had existing DTCs with three (50%) having a subcommittee on antimicrobials. Seventy-five percent had infection control committees, with presence even in centers without DTCs. Chairpersons and secretaries of the DTCs were predominantly physicians (83.3%) and pharmacists (100%), respectively. Hospital formularies were available in five facilities with DTCs, while one facility without a DTC had an Essential Medicines Committee responsible for developing and updating the hospital formulary. The evaluation of ADRs was undertaken by pharmacovigilance units in nine facilities. Overall, DTCs were present in only half of the surveyed facilities and most were performing their statutory functions sub-optimally. The functioning of DTCs can be improved through government directives and mechanisms for continuous evaluation of activities.Keywords
This publication has 45 references indexed in Scilit:
- Are payers treating orphan drugs differently?Journal of Market Access & Health Policy, 2014
- The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committeesEuropean Journal of Clinical Pharmacology, 2013
- Selection of medicines in Chilean public hospitals: an exploratory studyBMC Health Services Research, 2013
- Assessing equity in health care through the national health insurance schemes of Nigeria and Ghana: a review-based comparative analysisInternational Journal for Equity in Health, 2013
- Sale strategies of pharmaceutical companies in a “pharmerging” country: The problems will not improve if the gaps remainHealth Policy, 2012
- A Prescription for Improving Drug Formulary Decision MakingPLOS Medicine, 2012
- The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in StockholmBasic & Clinical Pharmacology & Toxicology, 2011
- Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevanceExpert Review of Pharmacoeconomics & Outcomes Research, 2009
- The Application of Adverse Drug Reaction Data to Drug Choice Decisions Made by Pharmacy and Therapeutics CommitteesDrug Safety, 1998
- Institutional FormulariesPharmacoEconomics, 1992